Evolva signs sales deed of operations to Lallemand affiliate for a cool US$23M

Related Articles

Lungs with cystic fibrosis

NUTRITION & HEALTH NEWS

23 Feb 2024 --- Cystic fibrosis (CF) is a chronic condition that causes the build-up of mucus in the lungs, airways and digestive system, which often leads to... Read More

baby with bottle formula

NUTRITION & HEALTH NEWS

13 Feb 2024 --- Researchers at the food tech start-up Yali Bio, supported by the US National Institutes of Health (NIH), have utilized precision fermentation to create a... Read More

A woman stands next to a bunch of servers while checking her laptop.

NUTRITION & HEALTH NEWS

05 Feb 2024 --- Digitalization, next-generation technologies and scientific advancements are set to shake up the supplement and nutraceutical industry in the coming... Read More

Oleic-Palmitic-Oleic human milk fat analog

NUTRITION & HEALTH NEWS

01 Feb 2024 --- Biotechnology company Checkerspot has developed a new source of milk fat analog, oleic-palmitic-oleic, containing palmitic acid in sn-2 position in the... Read More

Hands holding beer glass.

BUSINESS NEWS

26 Jan 2024 --- Lallemand Bio-Ingredients’ recent acquisition of Swiss biotechnology firm Evolva for a reported CHF20 million (∼US$23 million) will enable the... Read More

trans